热线电话: 021-34661275
产品分类/PRODUCT CLASSIFICATION

上海细胞库

人源细胞系| 稳转细胞系| 基因敲除株| 基因点突变细胞株| 基因过表达细胞株| 重组细胞系| 猪的细胞系| 马细胞系| 兔的细胞系| 犬的细胞系| 山羊的细胞系| 鱼的细胞系| 猴的细胞系| 仓鼠的细胞系| 狗的细胞系| 牛的细胞| 大鼠细胞系| 小鼠细胞系| 其他细胞系|

原代细胞

原代细胞| 永生化细胞|

细胞培养

血清| 无血清冻存| 细胞培养试剂盒| 普通培养基| 完全培养基| 细胞污染预防| 细胞污染清除| 细胞培养辅助试剂|

细胞服务

STR鉴定服务| ATCC代购服务|

酶联试剂盒

人ELISA试剂盒| 大鼠ELISA试剂盒| 小鼠ELISA试剂盒| 兔ELISA试剂盒| 猪ELISA试剂盒| 鱼ELISA试剂盒| 牛ELISA试剂盒| 犬ELISA试剂盒| 鸭ELISA试剂盒| 豚鼠ELISA试剂盒| 鸡ELISA试剂盒| 绵羊ELISA试剂盒| 山羊ELISA试剂盒| 仓鼠ELISA试剂盒| 植物ELISA试剂盒| 药残留类试剂盒| 其他ELISA试剂盒|

生化试剂盒

生化试剂盒| 微量法检测盒| 分光法检测盒| 胶体金检测盒|

PCR试剂盒

荧光探针PCR试剂盒| 染料荧光PCR试剂盒| 核酸扩增/纯化| 普通PCR检测试剂盒| 质粒菌种感受态|

抗体蛋白

蛋白多肽| 抗体| 免疫组化| 免疫球蛋白|

试剂耗材

标准试液| 科研试剂| 缓 冲 液| 实验耗材| 高效液相色谱对照品|

首页 > 抗体蛋白 > 抗体
Brilliant Violet 421™ anti-mouse/human CD11b
产品名称：
Brilliant Violet 421™ anti-mouse/human CD11b
产品类别：
抗体
产品编号：
101235
产品应用：
101235
[价格]
规格 价格 库存
125µL ￥ 1980 1

产品详情

Product Details

Verified Reactivity
Mouse, Human, Cynomolgus, Rhesus
Reported Reactivity
Chimpanzee, Baboon, Rabbit
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C57BL/10 splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).
Preparation
The antibody was purified by affinity chromatography and conjugated with Brilliant Violet 421? under optimal conditions.
Concentration
?g sizes: 0.2 mg/mL
?L sizes: lot-specific (to obtain lot-specific concentration, please enter the lot number in our Concentration and Expiration Lookup or Certificate of Analysis online tools.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining using the ?g size, the suggested use of this reagent is ≤ 0.25 ?g per million cells in 100 ?L volume. For flow cytometric staining using the ?L sizes, the suggested use of this reagent is 5 ?L per million cells in 100 ?L staining volume or 5 ?L per 100 ?L of whole blood. It is recommended that the reagent be titrated for optimal performance for each application.

Brilliant Violet 421? excites at 405 nm and emits at 421 nm. The standard bandpass filter 450/50 nm is recommended for detection. Brilliant Violet 421? is a trademark of Sirigen Group Ltd.


Learn more about Brilliant Violet?.

This product is subject to proprietary rights of Sirigen Inc. and is made and sold under license from Sirigen Inc. The purchase of this product conveys to the buyer a non-transferable right to use the purchased product for research purposes only. This product may not be resold or incorporated in any manner into another product for resale. Any use for therapeutics or diagnostics is strictly prohibited. This product is covered by U.S. Patent(s), pending patent applications and foreign equivalents.
Excitation Laser
Violet Laser (405 nm)
Application Notes

Clone M1/70 has been verified for?immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F).

Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1,4, in vitro blocking3,9,12, depletion2,8, immunofluorescence microscopy6,7,10, immunohistochemistry of acetone-fixed frozen sections5,11-13, and spatial biology (IBEX)35,36. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF? purified antibody (Endotoxin < 0.01 EU/?g, Azide-Free, 0.2 ?m filtered) (Cat. No. 101248).

Application References

(PubMed link indicates BioLegend citation)
  1. Springer T, et al. 1978. Eur. J. Immunol. 8:539. (IP)
  2. Ault K and Springer T. 1981. J. Immunol. 126:359. (Deplete)
  3. Springer TA, et al. 1982. Immunol. Rev. 68:171. (Block)
  4. Ho MK and Springer TA. 1983. J. Biol. Chem. 258:2766. (IP)
  5. Flotte TJ, et al. 1983. Am. J. Pathol. 111:112. (IHC)
  6. Noel GJ, et al. 1990. J. Clin. Invest. 85:208. (IF)
  7. Allen LA and Aderem A. 1996. J. Exp. Med. 184:627 (IF)
  8. D'Amico A and Wu L. 2003. J. Exp. Med. 198:293. (Deplete)
  9. Brickson SJ, et al. 2003. Appl Physiol. 95:969. (Block)
  10. Clatworthy MR and Smith KG. 2004. J. Exp. Med. 199:717. (IF)
  11. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  12. Zhang Y, et al. 2002. J. Immunol. 168:3088. (IHC)
  13. Iwasaki A and Kelsall BL. 2001. J. Immunol. 166:4884 (IHC, FC)
  14. Tailleux L. 2003. J. Exp. Med. 197:121. (Block, FC)
  15. Olver S, et al. 2006. Cancer Research 66:571. (FC)
  16. Tan SL, et al. 2006. J. Immunol. 176:2872. (FC) PubMed
  17. Ponomarev ED, et al. 2006. J. Immunol. 176:1402. (FC)
  18. Dzhagalov I, et al. 2007. Blood 109:1620. (FC)
  19. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  20. Rasmussen JW, et al. 2006. Infect. Immun.74:6590. PubMed
  21. Napimoga MH, et al. 2008. J. Immunol. 180:609. PubMed
  22. Elqaraz-Carmon V, et al. 2008. J. Lipid. Res. 49:1894. PubMed
  23. Kim DD, et al. 2008. Blood 112:1109. PubMed
  24. Guo Y, et al. 2008. Blood 112:480. PubMed
  25. Norian LA, et al. 2009. Cancer Res. 69:3086. (FC) PubMed
  26. Baumgartner CK, et al. 2010. J. Immunol. 184:573. PubMed
  27. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  28. Whiteland J, et al. 1995. J. Histochem. Cytochem. 43:313. (IHC)
  29. Weber GF, et al. 2014. J Exp Med. 211:1243. PubMed
  30. Ashok A, et al. 2015. Toxicol Sci. 143:64. PubMed
  31. Price PJ, et al. 2015. J Immunol. 194:1164. PubMed
  32. Doni A, et al. 2015. J Exp Med. 212:905. PubMed
  33. Ferreira R, et al. 2016. J Infect Dis. 213: 669 - 673. PubMed
  34. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  35. Radtke?AJ,?et al.?2020.?Proc Natl Acad Sci U S A.?117:33455-65. (SB)?PubMed
  36. Radtke?AJ,?et al.?2022.?Nat Protoc.?17:378-401. (SB)?PubMed
Product Citations
  1. Su Y, et al. 2022. J Hematol Oncol. 15:99. PubMed
  2. Doni A, et al. 2015. J Exp Med. 212:905. PubMed
  3. D?britz J, et al. 2016. Sci Rep. 6:20584. PubMed
  4. Chai Y, et al. 2016. PLoS One. 11: 0162853. PubMed
  5. Moderzynski K, et al. 2016. PLoS Negl Trop Dis. . PubMed
  6. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  7. Liu J, et al. 2019. Immunity. 50:600. PubMed
  8. Ilinykh PA, et al. 2020. Cell Host & Microbe. 27(6):976-991. PubMed
  9. Miller CM, et al. 2020. J Virol. 94:00:00. PubMed
  10. Li Q, et al. 2019. Neuron. 101:207. PubMed
  11. Yan L, et al. 2021. Front Cell Neurosci. 15:750373. PubMed
  12. Klemm F, et al. 2020. Cell. 181(7):1643-1660.e17. PubMed
  13. Chen J, et al. 2022. Nat Commun. 13:6759. PubMed
  14. Piirsalu M, et al. 2022. Cells. 11:. PubMed
  15. Kremenovic M, et al. 2022. J Immunother Cancer. 10:. PubMed
  16. Acharya N, et al. 2020. Immunity. 53(3):658-671.e6. PubMed
  17. Liu X, et al. 2013. Diabetes. 62:4228. PubMed
  18. Joseph R, et al. 2021. Br J Cancer. 125:176. PubMed
  19. Linnerbauer M, et al. 2022. Front Immunol. 12:800128. PubMed
  20. McDowell SAC, et al. 2021. Nat Cancer. 2:545. PubMed
  21. Talma N, et al. 2021. Aging Cell. 20:e13450. PubMed
  22. Ma C, et al. 2018. Science. 360:eaan5931. PubMed
  23. Currier MA, et al. 2017. Oncotarget. 8:17412. PubMed
  24. Hao F, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  25. Sugita J, et al. 2021. Nat Commun. 12:1910. PubMed
  26. Perner C, et al. 2020. Immunity. 53(5):1063-1077.e7. PubMed
  27. Xu D et al. 2018. Cell. 174(6):1477-1491 . PubMed
  28. Zirngibl F, et al. 2021. J Immunother Cancer. 9:. PubMed
  29. Salei N, et al. 2020. J Am Soc Nephrol. 31:257. PubMed
  30. Sokol CL et al. 2018. Immunity. 49(3):449-463 . PubMed
  31. Sabbagh MF et al. 2018. eLife. 7 pii: e36187. PubMed
  32. Yousef H, et al. 2018. Bio Protoc. 8:22. PubMed
  33. Mifflin L, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  34. Cassidy BR, et al. 2020. J Neuroinflammation. 17:259. PubMed
  35. Korangath P, et al. 2020. Bio Protoc. 10:e3822. PubMed
  36. Singh S, et al. 2021. Cell Host Microbe. 29(3):347-361.e12. PubMed
  37. Bryson BD, et al. 2019. Nat Commun. 10:2329. PubMed
  38. Cong J et al. 2018. Cell metabolism. 28(2):243-255 . PubMed
  39. Alikhanyan K, et al. 2021. Cancers (Basel). 13:. PubMed
  40. Progatzky F, et al. 2021. Nature. 599:125. PubMed
  41. Muraleedharan A, et al. 2021. Glia. 69:697. PubMed
  42. Knizkova D, et al. 2022. Nat Immunol. 23:1644. PubMed
  43. Weber G, et al. 2014. J Exp Med. 211:1243. PubMed
  44. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  45. Ruer-Laventie J, et al. 2020. Bio Protoc. e3531:10. PubMed
  46. Grzelak A, et al. 2018. Int J Mol Sci. 19:. PubMed
  47. Rashidi M, et al. 2019. J Immunol. 203:736. PubMed
  48. Momin N, et al. 2022. Nat Commun. 13:109. PubMed
  49. Jia P, et al. 2021. Nat Commun. 12:6535. PubMed
  50. Bennett M, et al. 2016. Proc Natl Acad Sci U S A. 113: 1738 - 1746. PubMed
  51. O'Connor T, et al. 2020. Cancer Cell. 36(3):250-267. PubMed
  52. Liakopoulos V, et al. 2018. Sci Rep. 8:13964. PubMed
  53. Kakizaki M, Watanabe R 2017. Neuropathology. 10.1111/neup.12386. PubMed
  54. Cosentino K, et al. 2022. Mol Cell. 82:933. PubMed
  55. Price P, et al. 2015. J Immunol. 194:1164. PubMed
  56. Kodama L, et al. 2020. Nat Neurosci. 1.074305556. PubMed
  57. Li H, et al. 2022. Gut Microbes. 14:2127456. PubMed
  58. Zhou T, et al. 2022. Sci Adv. 8:eabj9617. PubMed
  59. Han Y, et al. 2022. Int J Biol Sci. 18:5653. PubMed
  60. Ioannidis L, et al. 2016. J Immunol. 196: 1227 - 1238. PubMed
  61. Tummers B, et al. 2020. Immunity. 52(6):994-1006.e8. PubMed
  62. Logan T, et al. 2021. Cell. 184(18):4651-4668.e25. PubMed
  63. Di Mitri D, et al. 2019. Cell Rep. 28:2156. PubMed
  64. Toshiro Hirai et al. 2019. Immunity. 50(5):1249-1261 . PubMed
  65. Buzzelli JN, et al. 2019. Am J Physiol Gastrointest Liver Physiol. 316:G251. PubMed
  66. Mohamed E, et al. 2020. Immunity. 52(4):668-682.e7.. PubMed
  67. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
  68. Sakamoto K, et al. 2021. Immunity. 54:2321. PubMed
  69. Wieghofer P, et al. 2021. EMBO J. 40:e105123. PubMed
  70. Song J, et al. 2021. Am J Physiol Heart Circ Physiol. 320:H323. PubMed
  71. Pizzurro GA, et al. 2021. Cancers (Basel). 13:. PubMed
  72. Fujii T, et al. 2021. Bone Res. 9:4. PubMed
  73. Xu G, et al. 2020. Cell Rep. 32:108170. PubMed
  74. Motozono C, et al. 2015. J Biol Chem. 290: 18924 - 18933. PubMed
  75. Qi F, et al. 2019. Front Microbiol. 2.140277778. PubMed
  76. Ponzetta A, et al. 2020. Cell. 178(2):346-360.e24.. PubMed
  77. Richardson ET, et al. 2015. PLoS One. 10: 1371. PubMed
  78. Wedekind MF, et al. 2021. iScience. 24(7):102759. PubMed
  79. Laban H, et al. 2018. J Cell Biol. 217:1503. PubMed
  80. Yousef H, et al. 2019. Nat Med. 25:988. PubMed
  81. Xia D, et al. 2022. Mol Neurodegener. 17:41. PubMed
  82. Pribyl M, et al. 2020. Mol Oncol. 2.252083333. PubMed
  83. Damgaard RB et al. 2016. Cell. 166(5):1215-1230 . PubMed
  84. Mairhofer D, et al. 2015. J Invest Dermatol. 135: 2785-93. PubMed
  85. Skucha A, et al. 2018. Nat Commun. 9:1983. PubMed
  86. Molgora M, et al. 2020. Cell. 182:886. PubMed
  87. Fedele C, et al. 2021. J Exp Med. 218: . PubMed
  88. Sakurai Y, et al. 2021. Pharmaceutics. 13:. PubMed
  89. Heil J, et al. 2021. Nat Commun. 12:6963. PubMed
  90. Katzmarski N, et al. 2021. Nat Immunol. 22:1382. PubMed
  91. Zhong C, et al. 2021. J Virol. 95:e0092521. PubMed
  92. Maas RR, et al. 2021. Nat Protoc. 16:4692. PubMed
  93. Yin Z, et al. 2017. Neurobiol Aging. 10.1016/j.neurobiolaging.2017.03.021. PubMed
  94. Geng X, et al. 2018. Aging (Albany NY). 10:1415. PubMed
  95. Knox T, et al. 2019. Sci Rep. 9:6136. PubMed
  96. Krivtsov AV, et al. 2020. Cancer Cell. 36(6):660-673.e11.. PubMed
  97. Jolly A, et al. 2022. Cell Rep Methods. 2:100315. PubMed
  98. Guan D, et al. 2021. Cell Death Dis. 12:431. PubMed
  99. Xiao Z, et al. 2022. Mater Today Bio. 15:100297. PubMed
  100. Sakamoto K, et al. 2022. STAR Protoc. 3:101052. PubMed
  101. Verma M, et al. 2021. J Exp Med. 218:. PubMed
  102. Lee GR, et al. 2021. JCI Insight. 6:. PubMed
  103. Chetty A, et al. 2021. Cell Host Microbe. 29:579. PubMed
  104. Nakayama Y, et al. 2020. Proc Natl Acad Sci U S A. 117:14365. PubMed
  105. Zukauskas A, et al. 2018. mSphere. 3:e00303. PubMed
  106. Das A, et al. 2020. J Bone Miner Res. 36:199. PubMed
  107. Rappe JCF, et al. 2021. J Exp Med. 218:. PubMed
  108. Caporarello N, et al. 2022. Nat Commun. 13:4170. PubMed
  109. Reinert L, et al. 2016. Nat Commun. 7:13348. PubMed
  110. Chen MB, et al. 2020. Cell Rep. 30:4418. PubMed
  111. Li Z et al. 2018. Immunity. 49(4):640-653 . PubMed
  112. Cho C et al. 2017. Neuron. 95(5):1056-1073 . PubMed
  113. Koda S, et al. 2021. Front Immunol. 12:754208. PubMed
  114. Bae S, et al. 2021. Cell Reports. 35(11):109264. PubMed
  115. Harvey RE et al. 2017. Endocrinology. 158(7):2179-2189 . PubMed
  116. Kim I et al. 2015. Brain and behavior. 5(12):e00403 . PubMed
RRID
AB_10897942 (BioLegend Cat. No. 101235) AB_2562904 (BioLegend Cat. No. 101251) AB_11203704 (BioLegend Cat. No. 101236)

Antigen Details

Structure
Integrin family, associates with integrin β2 (CD18), 170 kD
Distribution

Granulocytes, monocytes/macrophages, dendritic cells, NK cells, subsets of T and B cells

Function
Adhesion, chemotaxis
Ligand/Receptor
ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, fibrinogen
Cell Type
B cells, Dendritic cells, Granulocytes, Macrophages, Monocytes, Neutrophils, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Coxon A, et al. 1996. Immunity 5:653.

Gene ID
16409 View all products for this Gene ID 3684 View all products for this Gene ID
UniProt
View information about CD11b on UniProt.org

联系我们

TEL：021-34661275 　点击拨打热线